[Bioclinical study of the electro-immunodiffusion technic for the assay of serum alpha fetoprotein].
The author discusses the result that may be expected in clinical medicine from an electro-immunodiffusion method for the detection of alpha-foetoprotein. The samples studied were obtained from pregnant women, patients with liver cell carcinoma or severe digestive diseases, whether malignant or not, and a few amniotic fluids and sera obtained from the umbilical cord. This simple, rapid method is characterized by a sensitivity threshold of about 300 ng/ml and permits one to detect about 75% of cases of liver cell carcinoma.
D000328:Adult; D000653:Amniotic Fluid / Q000032:analysis; D006528:Carcinoma, Hepatocellular / Q000097:blood; D002648:Child; D003937:Diagnosis, Differential; D005260:Female; D005312:Fetal Blood / Q000032:analysis; D005326:Fetal Proteins / Q000032:analysis*; D005767:Gastrointestinal Diseases / Q000097:blood; D005770:Gastrointestinal Neoplasms / Q000097:blood; D006801:Humans; D005779:Immunodiffusion / Q000379:methods*; D008107:Liver Diseases / Q000097:blood; D008113:Liver Neoplasms / Q000097:blood; D008297:Male; D011247:Pregnancy; D000509:alpha-Fetoproteins / Q000032:analysis*
D005326:Fetal Proteins; D000509:alpha-Fetoproteins
Etude bioclinique du procédé d'électro-immunodiffusion pour la recherche de l'alpha-foetoprotéine sérique